50
Participants
Start Date
September 30, 2011
Primary Completion Date
August 15, 2017
Study Completion Date
March 22, 2018
pomalidomide
Given orally
bortezomib
Given IV
dexamethasone
Given orally
laboratory biomarker analysis
Optional correlative studies
gene expression analysis
Optional correlative studies
Mayo Clinic, Rochester
Mayo Clinic in Arizona, Scottsdale
Mayo Clinic in Florida, Jacksonville
Lead Sponsor
National Cancer Institute (NCI)
NIH
Mayo Clinic
OTHER